在重症监护室的败血症患者中,血红蛋白糖化指数和痴呆风险之间的关联
相关实验视频
Updated: Jul 14, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
1Department of Emergency, Peking University People's Hospital, Beijing, China.
Balkan medical journal
|November 5, 2025
概括
血红蛋白糖化指数 (HGI) 与重症监护室 (ICU) 败血症患者 Delirium 风险和死亡率的增加有关. 较低的HGI水平与更高的妄想风险有关,这表明HGI作为预后生物标志物.
科学领域:
- 关键护理医学 关键护理医学
- 代谢障碍 代谢障碍 代谢障碍
- 神经学 神经学
背景情况:
- 败血症相关的脑病变是ICU患者常见的并发症.
- 血红蛋白糖化指数 (HGI) 和败血症患者的痴呆症之间的关联仍然不清楚.
研究的目的:
- 调查HGI与进入ICU的败血症患者 Delirium风险之间的关系.
- 探索HGI与短期预后的关联,包括30天全因死亡率.
主要方法:
- 这是一项回顾性队列研究,利用医学信息中心密切护理IV (MIMIC-IV) 数据库的数据.
- 根据HGI水平,患者被分为三层.
- 使用后勤回归,Cox比例危险模型和受限立方线分析来检查HGI与临床结果的联系.
主要成果:
- 总共分析了3744名败血症患者.
- 与参考组 (T2) 相比,较高的HGI水平 (T1和T3) 与 Delirium 风险增加有关.
- 较低的HGI水平 (T1) 与更高的30天全因死亡风险有关,在HGI和妄想风险之间观察到U形关系.
结论:
- 血红蛋白糖化指数 (HGI) 独立地与ICU败血症患者的痴呆风险和短期预后有关.
- 在这种患者群体中,HGI可以作为预后风险分层的有价值生物标志物.
- 确定了一个值效应,表明一个特定的HGI水平,低于这个水平,风险会显著变化.
更多相关视频
06:26Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells
Published on: February 14, 2020
17.1K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
703
相关概念视频
SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...